This page includes the latest FDA filings for Agile Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | AGRX | DUNS 102678187 |
Device Company | Device | Date |
---|---|---|
Agile Therapeutics, Inc., Bayer AG, Corium International, Inc., Eurofins Lancaster Laboratories, Inc, SGS North America Inc., TPM Laboratories, Inc., Pace Analytical Life Sciences | Prescription Medication | 2024-07-12 |
Agile Therapeutics, Inc., Bayer AG, Corium International, Inc., Eurofins Lancaster Laboratories, Inc, SGS North America Inc., TPM Laboratories, Inc., Pace Analytical Life Sciences | Prescription Medication | 2023-11-18 |
Agile Therapeutics, Inc., Bayer AG, Corium International, Inc., Eurofins Lancaster Laboratories, Inc, SGS North America Inc., TPM Laboratories, Inc., Pace Analytical Life Sciences | Prescription Medication | 2022-05-13 |
Agile Therapeutics, Inc., Bayer AG, Corium International, Inc., Eurofins Lancaster Laboratories, Inc, SGS North America Inc., TPM Laboratories, Inc., Pace Analytical Life Sciences | Prescription Medication | 2021-12-08 |
Agile Therapeutics, Inc., Bayer AG, Corium International, Inc., Eurofins Lancaster Laboratories, Inc, SGS North America Inc., TPM Laboratories, Inc., Pace Analytical Life Sciences | Prescription Medication | 2020-09-12 |
Agile Therapeutics, Inc. | Twirla | 2020-09-11 |
NCAGE Code | 8QBG9 | AGILE THERAPEUTICS, INC. |
SEC | 0001261249 | AGILE THERAPEUTICS INC of DELAWARE |